Trials / Conditions / Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
5 registered clinical trials studyying Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Canc NCT02567422 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Hea NCT02775812 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Recei NCT02381535 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreate NCT01935921 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy NCT01810913 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |